Can-Fite BioPharma CANF
NYSE CANF
$1.89 0.00 (-0.02%)
As of: Oct 21, 2026 · 3:21 PM EDT

Can-Fite BioPharma (CANF) Net Cash Flow (2012 - 2013)

Updated

Can-Fite BioPharma's Net Cash Flow came in at $693,000 for FY2025, up 21.8% from $569,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Net Cash Flow (2012 - 2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Net Cash Flow data covers 11 years.

  • Net Cash Flow carries a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
  • The five-year range for annual Net Cash Flow is -$3.91 million (FY2021) to $1.2 million (FY2023).
  • Per Business Quant, earlier years put Net Cash Flow at $569,000 in FY2024 (-52.7%), $1.2 million in FY2023, -$1.3 million in FY2022 and -$3.91 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -1.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -2.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.94 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -4.43 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -722.00 Mn
10 Can-Fite BioPharma 1.56 Mn -18.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.20 Mn
Sep 30, 2013 -1.39 Mn
Jun 30, 2013 3.21 Mn
Dec 31, 2012 -2.76 Mn
Sep 30, 2012 -381,325.47
Jun 30, 2012 8,133.94
API Access

Can-Fite BioPharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CANF&period=max&api_key=YOUR_API_KEY